Slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising. If you continue browsing the site, you agree to the use of cookies on this website. See our User Agreement and Privacy Policy.

Slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising. If you continue browsing the site, you agree to the use of cookies on this website. See our Privacy Policy and User Agreement for details.

2.
Executive Summary
2
Colorectal cancer, also known as bowel cancer and colon cancer, is the development of the cancer in the colon
or rectum. A cancer is the abnormal growth of the cells that have the ability to invade or spread to the other
parts of the body. Colorectal cancer begins when the healthy cells in the lining of the colon or rectum changes
and grows out of control, forming a mass called tumor. A tumor can be cancerous or benign. A cancerous tumor
is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can
grow but will not spread. These changes usually take years to develop.
Screening for colorectal cancer is effective not only for early detection but also for prevention. Diagnosis of
colorectal cancer through screening tends to occur 2-3 years before diagnosis of cases with symptoms. CRC
Screening is broadly divided into Structural Examination and Stool Tests. Structural examination is further
divide into Flexible Sigmoidography, Colonoscopy and Computed Tomographic Colonography, whereas Stool
Tests are divided into Occult blood and DNA tests.
Colorectal cancer diagnostic market is expected to grow in future due to increasing disposable income,
increasing ageing population and cancer incidences and rising healthcare expenditure. Key trends of this market
include launch of branded and advanced diagnosis and technology innovation. However, there are some factors
which can hinder the market growth including stringent legal norms, high cost, need for high quality of
screening process and dearth of expertise.
The report “Colorectal Cancer Diagnostics Market with Focus on DNA-based Tests: Industry Analysis &
Outlook (2018-2025)” by Koncept Analytics provides an extensive research and detailed analysis of the present
market along with future outlook. The report discusses the major growth drivers and challenges of the market,
covering the U.S., Europe and Asia. The report profiles the key players of the market including Epigenomics,
Exact Sciences Corporation, VoilitionRx Ltd and Quest Diagnostics.
Colorectal Cancer Diagnostic Market with Focus on DNA-Based Tests:
Industry Analysis & Outlook (2018-2025)

3.
Colorectal Cancer Diagnostic market is likely to grow with increasing awareness about CRC
screening tests among the population as well as increasing affordability of healthcare
expenditure by households.
3Colorectal Cancer Diagnostic Market with Focus on DNA-Based
Tests: Industry Analysis & Outlook (2018-2025)
• Global colorectal cancer incidences are expected to
reach …million in the year 2022, increasing from
…million in the year 2017 at a CAGR of ..%.
• The U.S. CRC screening test market volume is expected
to reach ...million in the year 2022, , increasing from
..million in 2017.
• In year 2025, the U.S. CRC screening receiving patient
volume is expected to reach ..million, increasing from
..million in 2018, at a CAGR of ..%.
The U.S. CRC Screening Test Market Volume Forecast (2017-2022)
Global Colorectal Cancer Incidences Forecast (2017-2022)
The U.S. CRC Screening Receiving Patient Volume Forecast (2018-2025)
2017 2018 2019 2020 2021 2022
Million
2017 2018 2019 2020 2021 2022
Million
2018 2019 2020 2021 2022 2023 2024 2025
Million

5.
Koncept Analytics
CS-36, First Floor, Ansal Plaza
Vaishali, Ghaziabad,
U.P. – 201010
T: +91-120-4130959
M: +91-9811715635
vikas@konceptanalytics.com
Contact Us:
www.konceptanalytics.com
This is a licensed product of Koncept Analytics. You cannot reproduce, publish, distribute, publicly display, sell or create
other works from this report or use them in any way for commercial purpose without our prior permission. Further, you
cannot copy this material, by any means (including electronic copies), for distribution to others unless you have purchased
the corporate license of this report.
We believe the sources are reliable, but Koncept Analytics does not warranty the accuracy or completeness of the data. The
data presented in the report is updated at the publication date but is subject to change at subsequent releases. All possible
efforts have been made to ensure accuracy of data. However, investors should not completely rely on the information given
in this report and must make decisions based on their own investment strategy, risk management and capital adequacy.
5
Disclaimer
Colorectal Cancer Diagnostic Market with Focus on DNA-Based Tests:
Industry Analysis & Outlook (2018-2025)